{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,22]],"date-time":"2026-06-22T13:42:09Z","timestamp":1782135729409,"version":"3.54.5"},"reference-count":28,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,11,10]]},"DOI":"10.7759\/cureus.73403","type":"journal-article","created":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T01:42:46Z","timestamp":1731289366000},"source":"Crossref","is-referenced-by-count":1,"title":["Aplastic Anemia: Demographic and Clinical Characteristics in Costa Rica"],"prefix":"10.7759","author":[{"given":"Mar\u00eda","family":"Rodr\u00edguez-Sevilla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathia","family":"Valverde-Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Garc\u00eda-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Sanabria-Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Echeverri-McCandless","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebasti\u00e1n","family":"Rojas-Chaves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.19236","article-title":"Guidelines for the diagnosis and management of adult aplastic anaemia: a British Society for Haematology Guideline","volume":"204","author":"Kulasekararaj A","year":"2024","unstructured":"Kulasekararaj A, Cavenagh J, Dokal I, et al.. Guidelines for the diagnosis and management of adult aplastic anaemia: a British Society for Haematology Guideline. Br J Haematol. 2024, 204:784-804. 10.1111\/bjh.19236","journal-title":"Br J Haematol"},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1016\/j.hoc.2018.03.003","article-title":"Recent advances and long-term results of medical treatment of acquired aplastic anemia: are patients cured?","volume":"32","author":"Scheinberg P","year":"2018","unstructured":"Scheinberg P. Recent advances and long-term results of medical treatment of acquired aplastic anemia: are patients cured?. Hematol Oncol Clin North Am. 2018, 32:609-18. 10.1016\/j.hoc.2018.03.003","journal-title":"Hematol Oncol Clin North Am"},{"key":"ref3","doi-asserted-by":"publisher","DOI":"10.1080\/17474086.2017.1313700","article-title":"Updates on the pathophysiology and treatment of aplastic anemia: a comprehensive review","volume":"10","author":"Boddu PC","year":"2017","unstructured":"Boddu PC, Kadia TM. Updates on the pathophysiology and treatment of aplastic anemia: a comprehensive review. Expert Rev Hematol. 2017, 10:433-48. 10.1080\/17474086.2017.1313700","journal-title":"Expert Rev Hematol"},{"key":"ref4","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMra1413485","article-title":"Aplastic anemia","volume":"379","author":"Young NS","year":"2018","unstructured":"Young NS. Aplastic anemia. N Engl J Med. 2018, 379:1643-56. 10.1056\/NEJMra1413485","journal-title":"N Engl J Med"},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2005-01-0161","article-title":"The epidemiology of aplastic anemia in Thailand","volume":"107","author":"Issaragrisil S","year":"2006","unstructured":"Issaragrisil S, Kaufman DW, Anderson T, Chansung K, Leaverton PE, Shapiro S, Young NS. The epidemiology of aplastic anemia in Thailand. Blood. 2006, 107:1299-307. 10.1182\/blood-2005-01-0161","journal-title":"Blood"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2008.002642","article-title":"Incidence and risk factors of aplastic anemia in Latin American countries: the LATIN case-control study","volume":"94","author":"Maluf E","year":"2009","unstructured":"Maluf E, Hamerschlak N, Cavalcanti AB, et al.. Incidence and risk factors of aplastic anemia in Latin American countries: the LATIN case-control study. Haematologica. 2009, 94:1220-6. 10.3324\/haematol.2008.002642","journal-title":"Haematologica"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-015-1787-z","article-title":"The diagnosis and treatment of aplastic anemia: a review","volume":"101","author":"Miano M","year":"2015","unstructured":"Miano M, Dufour C. The diagnosis and treatment of aplastic anemia: a review. Int J Hematol. 2015, 101:527-35. 10.1007\/s12185-015-1787-z","journal-title":"Int J Hematol"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1053\/j.seminhematol.2013.03.028","article-title":"Aplastic anemia: what have we learned from animal models and from the clinic","volume":"50","author":"Scheinberg P","year":"2013","unstructured":"Scheinberg P, Chen J. Aplastic anemia: what have we learned from animal models and from the clinic. Semin Hematol. 2013, 50:156-64. 10.1053\/j.seminhematol.2013.03.028","journal-title":"Semin Hematol"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.13853","article-title":"Guidelines for the diagnosis and management of adult aplastic anaemia","volume":"172","author":"Killick SB","year":"2016","unstructured":"Killick SB, Bown N, Cavenagh J, et al.. Guidelines for the diagnosis and management of adult aplastic anaemia. Br J Haematol. 2016, 172:187-207. 10.1111\/bjh.13853","journal-title":"Br J Haematol"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.51481\/amc.v62i3.1075","article-title":"[Aplastic anemia in the pediatric population of Costa Rica: 10-year experience]","volume":"62","author":"Rojas-Jim\u00e9nez S","year":"2020","unstructured":"Rojas-Jim\u00e9nez S, Valverde-Mu\u00f1oz K. [Aplastic anemia in the pediatric population of Costa Rica: 10-year experience]. Acta M\u00e9d Costarric. 2020, 62:119-25. 10.51481\/amc.v62i3.1075","journal-title":"Acta M\u00e9d Costarric"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.20988","article-title":"Treatment for children with severe aplastic anemia and sickle cell disease in low income countries in Latin America: a report on the recent meetings of the Monza International School of Pediatric Hematology\/Oncology (MISPHO): part III","volume":"48","author":"Howard SC","year":"2007","unstructured":"Howard SC, Wilimas JA, Flores A, et al.. Treatment for children with severe aplastic anemia and sickle cell disease in low income countries in Latin America: a report on the recent meetings of the Monza International School of Pediatric Hematology\/Oncology (MISPHO): part III. Pediatr Blood Cancer. 2007, 48:598-9. 10.1002\/pbc.20988","journal-title":"Pediatr Blood Cancer"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1080\/16078454.2019.1711344","article-title":"Epidemiology of aplastic anemia: a study of 1324 cases","volume":"25","author":"Ahmed P","year":"2020","unstructured":"Ahmed P, Chaudhry QU, Satti TM, et al.. Epidemiology of aplastic anemia: a study of 1324 cases. Hematology. 2020, 25:48-54. 10.1080\/16078454.2019.1711344","journal-title":"Hematology"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.54393\/pbmj.v5i5.437","article-title":"Spectrum of aplastic anaemia; presentation, etiology and overall survival: ASpectrum of aplastic anaemia: presentation, etiology and overall survival-a tertiary care hospital experience tertiary care hospital experience: spectrum of aplastic anaemia","volume":"5","author":"Ashraf S","year":"2022","unstructured":"Ashraf S, Rashid A, Mughal Z, et al.. Spectrum of aplastic anaemia; presentation, etiology and overall survival: ASpectrum of aplastic anaemia: presentation, etiology and overall survival-a tertiary care hospital experience tertiary care hospital experience: spectrum of aplastic anaemia. Pak BioMed J. 2022, 5:330-4. 10.54393\/pbmj.v5i5.437","journal-title":"Pak BioMed J"},{"key":"ref14","article-title":"Survival in primary a plastic anaemia; experience with 20 cases from a tertiary hospital in Nigeria","volume":"9","author":"Arewa OP","year":"2009","unstructured":"Arewa OP, Akinola NO. Survival in primary a plastic anaemia; experience with 20 cases from a tertiary hospital in Nigeria. Afr Health Sci. 2009, 9:290-3.","journal-title":"Afr Health Sci"},{"key":"ref15","article-title":"Clinico-hematological profile of aplastic anemia in southern Odisha: an institutional study","volume":"5","author":"Bal AK","year":"2019","unstructured":"Bal AK, Bihari BB, Mohanty S, et al.. Clinico-hematological profile of aplastic anemia in southern Odisha: an institutional study. Int J Med Res Prof. 2019, 5:34-7.","journal-title":"Int J Med Res Prof"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.2147\/IJGM.S335961","article-title":"An investigation of selected socio-demographic factors with aplastic anemia in Pakistan: a case-control study","volume":"14","author":"Syed MA","year":"2021","unstructured":"Syed MA, Rahman AA, Ghani A, et al.. An investigation of selected socio-demographic factors with aplastic anemia in Pakistan: a case-control study. Int J Gen Med. 2021, 14:8929-34. 10.2147\/IJGM.S335961","journal-title":"Int J Gen Med"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.4103\/mgmj.MGMJ_50_23","article-title":"Prevalence and risk factors of acquired aplastic anemia among men aged 15 years and above referred for hematological consultation at Parirenyatwa Group of Hospital Zimbabwe 2020-2022: a case-control study","volume":"10","author":"Makaza M","year":"2023","unstructured":"Makaza M, Mahaman Y, Abdoul R, et al.. Prevalence and risk factors of acquired aplastic anemia among men aged 15 years and above referred for hematological consultation at Parirenyatwa Group of Hospital Zimbabwe 2020-2022: a case-control study. MGM J Med Sci. 2023, 10:210-7. 10.4103\/mgmj.MGMJ_50_23","journal-title":"MGM J Med Sci"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000034862","article-title":"Aplastic anemia from past to the present: a bibliometric analysis with research trends and global productivity during 1980 to 2022","volume":"102","author":"Bulduk T","year":"2023","unstructured":"Bulduk T. Aplastic anemia from past to the present: a bibliometric analysis with research trends and global productivity during 1980 to 2022. Medicine (Baltimore). 2023, 102:e34862. 10.1097\/MD.0000000000034862","journal-title":"Medicine (Baltimore)"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.1159\/000499065","article-title":"Current treatment patterns of aplastic anemia in China: a prospective cohort registry study","volume":"142","author":"Zhu XF","year":"2019","unstructured":"Zhu XF, He HL, Wang SQ, et al.. Current treatment patterns of aplastic anemia in China: a prospective cohort registry study. Acta Haematol. 2019, 142:162-70. 10.1159\/000499065","journal-title":"Acta Haematol"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2024.1378432","article-title":"The state of the art in the treatment of severe aplastic anemia: immunotherapy and hematopoietic cell transplantation in children and adults","volume":"15","author":"Piekarska A","year":"2024","unstructured":"Piekarska A, Pawelec K, Szmigielska-Kap\u0142on A, Ussowicz M. The state of the art in the treatment of severe aplastic anemia: immunotherapy and hematopoietic cell transplantation in children and adults. Front Immunol. 2024, 15:1378432. 10.3389\/fimmu.2024.1378432","journal-title":"Front Immunol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.13057","article-title":"Low response rate to ATG-based immunosuppressive therapy in very severe aplastic anaemia - a Swedish nationwide cohort study","volume":"100","author":"Vaht K","year":"2018","unstructured":"Vaht K, G\u00f6ransson M, Carlson K, et al.. Low response rate to ATG-based immunosuppressive therapy in very severe aplastic anaemia - a Swedish nationwide cohort study. Eur J Haematol. 2018, 100:613-20. 10.1111\/ejh.13057","journal-title":"Eur J Haematol"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1007\/s00277-013-1674-8","article-title":"The efficacy of rabbit antithymocyte globulin with cyclosporine in comparison to horse antithymocyte globulin as a first-line treatment in adult patients with severe aplastic anemia: a single-center retrospective study","volume":"92","author":"Shin SH","year":"2013","unstructured":"Shin SH, Yoon JH, Yahng SA, et al.. The efficacy of rabbit antithymocyte globulin with cyclosporine in comparison to horse antithymocyte globulin as a first-line treatment in adult patients with severe aplastic anemia: a single-center retrospective study. Ann Hematol. 2013, 92:817-24. 10.1007\/s00277-013-1674-8","journal-title":"Ann Hematol"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-017-2179-3","article-title":"Meta-analysis of treatment with rabbit and horse antithymocyte globulin for aplastic anemia","volume":"105","author":"Hayakawa J","year":"2017","unstructured":"Hayakawa J, Kanda J, Akahoshi Y, et al.. Meta-analysis of treatment with rabbit and horse antithymocyte globulin for aplastic anemia. Int J Hematol. 2017, 105:578-86. 10.1007\/s12185-017-2179-3","journal-title":"Int J Hematol"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.13125","article-title":"Cost and complications are limitations in resource-constrained settings for equine anti-thymocyte globulin","volume":"101","author":"Mishra K","year":"2018","unstructured":"Mishra K, Jandial A, Lad D, Prakash G, Khadwal A, Varma N, Malhotra P. Cost and complications are limitations in resource-constrained settings for equine anti-thymocyte globulin. Eur J Haematol. 2018, 101:421. 10.1111\/ejh.13125","journal-title":"Eur J Haematol"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.10075","article-title":"Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation (EBMT)","volume":"92","author":"Locasciulli A","year":"2007","unstructured":"Locasciulli A, Oneto R, Bacigalupo A, et al.. Outcome of patients with acquired aplastic anemia given first line bone marrow transplantation or immunosuppressive treatment in the last decade: a report from the European Group for Blood and Marrow Transplantation (EBMT). Haematologica. 2007, 92:11-8. 10.3324\/haematol.10075","journal-title":"Haematologica"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2009.018267","article-title":"Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA Working Party","volume":"95","author":"Bacigalupo A","year":"2010","unstructured":"Bacigalupo A, Socie' G, Lanino E, et al.. Fludarabine, cyclophosphamide, antithymocyte globulin, with or without low dose total body irradiation, for alternative donor transplants, in acquired severe aplastic anemia: a retrospective study from the EBMT-SAA Working Party. Haematologica. 2010, 95:976-82. 10.3324\/haematol.2009.018267","journal-title":"Haematologica"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1007\/s12185-016-2037-8","article-title":"Bone marrow transplantation versus immunosuppressive therapy in patients with acquired severe aplastic anemia","volume":"104","author":"Bacigalupo A","year":"2016","unstructured":"Bacigalupo A, Giammarco S, Sica S. Bone marrow transplantation versus immunosuppressive therapy in patients with acquired severe aplastic anemia. Int J Hematol. 2016, 104:168-74. 10.1007\/s12185-016-2037-8","journal-title":"Int J Hematol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2017.169862","article-title":"Incidence and outcome of acquired aplastic anemia: real-world data from patients diagnosed in Sweden from 2000-2011","volume":"102","author":"Vaht K","year":"2017","unstructured":"Vaht K, G\u00f6ransson M, Carlson K, et al.. Incidence and outcome of acquired aplastic anemia: real-world data from patients diagnosed in Sweden from 2000-2011. Haematologica. 2017, 102:1683-90. 10.3324\/haematol.2017.169862","journal-title":"Haematologica"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/207281-aplastic-anemia-demographic-and-clinical-characteristics-in-costa-rica","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T01:42:48Z","timestamp":1731289368000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/207281-aplastic-anemia-demographic-and-clinical-characteristics-in-costa-rica"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11,10]]},"references-count":28,"URL":"https:\/\/doi.org\/10.7759\/cureus.73403","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2024,11,10]]}}}